Early Life
Jordi Rubiralta, a Spanish citizen, is part of the Rubiralta family, known for their significant presence in the diagnostics industry. The family's roots in business trace back to Josep María Rubiralta and Francisco Rubiralta, who founded a health products distribution company, Izasa, in 1966, which later evolved into Werfen.
Rise to Success
Jordi Rubiralta, along with his brothers, has been instrumental in the growth and success of Werfen. He served as the chairman of Werfen until 2019. Werfen has become a global leader in in vitro diagnostics, specializing in Hemostasis, Acute Care Diagnostics, and Autoimmunity. The company's success is reflected in its significant revenue and market share in key diagnostic areas. Jordi Rubiralta's leadership helped Werfen expand, particularly through acquisitions in the United States and Germany, including Tem and Accriva Diagnostics.
Key Business Strategies
The family's strategy has focused on specialization, innovation, and controlled expansion, particularly in high-complexity areas of diagnostics. Werfen's focus on advanced diagnostics has set it apart. His family office, Yukon Capital, has engaged in high-profile real estate transactions in Spain, further diversifying the family's business interests. Since 2013, Jordi Rubiralta has been a board member and was previously the chairman of Werfen until 2019.
Philanthropy
Details on Rubiralta's specific philanthropic endeavors are currently unavailable.
